Table 1.
Readability comparison between various information sources using Flesch-Kincaid readability score
Questions Posed | Flesch-Kincaid Score (p value) |
---|---|
General information about prostate cancer | |
ChatGPT | 43.0 ± 2.9 |
ChatGPT (Year 8) | 57.7 ± 2.9 |
Cancer Council Australia | 51.8 (p = 0.09, p = 0.11) |
UpToDate (Basics) | 65.4 (p <0.05, p = 0.18) |
Mayo Clinic | 53.5 (p <0.05, p = 0.14) |
General information about prostate cancer screening | |
ChatGPT | 34.9 ± 2.8 |
ChatGPT (Year 8) | 45.5 ± 10.9 |
UpToDate (Basics) | 71.6 (p <0.05, p = 0.06) |
UptoDate (Beyond Basics) | 45.5 (p = 0.14, p = 1) |
Low risk prostate cancer treatment | |
ChatGPT | 18.6 ± 1.8 |
ChatGPT (Year 8) | 36.7 ± 2.2 |
UpToDate (Basics) | 52.3 (p <0.05, p <0.05) |
Advanced prostate cancer treatment | |
ChatGPT | 28.4 ± 3.3 |
ChatGPT (Year 8) | 46.6 ± 1.1 |
UpToDate (Beyond Basics) | 42.2 (p = 0.05, p = 0.06) |
General information about renal cell cancer | |
ChatGPT | 26.8 ± 4.0 |
ChatGPT (Year 8) | 55.1 ± 1.5 |
Cancer Council Australia | 48.2 (p <0.05, p <0.05) |
UptoDate (Basics) | 68.5 (p <0.05, p <0.05) |
UpToDate (Beyond Basics) | 43.8 (p <0.05, p <0.05) |
Mayo Clinic | 57.2 (p <0.05, p = 0.15) |
General information about bladder cancer | |
ChatGPT | 36.2 ± 2.9 |
ChatGPT (Year 8) | 51.6 ± 2.6 |
Cancer Council Australia | 42.4 (p = 0.17, p = 0.07) |
UpToDate (Basics) | 66.8 (p <0.05, p <0.05) |
Mayo Clinic | 50.3 (p <0.05, p = 0.33) |
Bladder cancer diagnosis and staging | |
ChatGPT | 35.6 ± 0.7 |
ChatGPT (Year 8) | 49.6 ± 1.6 |
UpToDate (Beyond Basics) | 42.6 (p <0.05, p <0.05) |
Non-muscle invasive bladder cancer treatment | |
ChatGPT | 25.9 ± 1.1 |
ChatGPT (Year 8) | 36.6 ± 1.3 |
UpToDate (Beyond Basics) | 37.8 (p <0.05, p = 0.06) |
Muscle invasive bladder cancer treatment | |
ChatGPT | 31.2 ± 3.6 |
ChatGPT (Year 8) | 61.1 ± 2.5 |
UpToDate (Beyond Basics) | 35.8 (p = 0.17, p <0.05) |